1717 K Street NW, Suite 900

Washington, DC 20006-5349

(877) 363-6376

HELPLINE

NEWS

ACTION ALERT: Request Support for Increased Research Funding

action_alertDear supporter of mesothelioma research.

We need your help!

In March, Congresswoman Carolyn Maloney (D-NY) developed a formal letter requesting the U.S. House of Representatives Appropriations Committee Defense Subcommittee dedicate $40 million for the Peer-Reviewed Cancer Research Program (PRCRP) in the Fiscal Year 2015 Defense Appropriations bill. The $40 million represents a $15 million increase over the 2014 level for the PRCRP. Mesothelioma is one of the cancers eligible to compete for funding under this program.

Since then, the Senate Appropriations Committee passed a funding level of $50 million for the PRCRP, which would double the program’s 2014 level. Representative Maloney is now requesting that the House Appropriations Defense Subcommittee agree to the Senate level for the program in conference on the final version of the Fiscal 2015 Defense Appropriations bill. This is the bill that will go to the President to be signed into law.

If the Congress agrees to the $50 million for the PRCRP, it would represent a significant increase in funding for all applicable cancers, including Defense-funded mesothelioma research.

A “Dear Colleague” email went out last week, urging support. So far, the letter has been signed by Representatives Michael Fitzpatrick (R-PA), Eleanor Holmes Norton (D-DC), Charlie Rangel (D-NY), Sander Levin (D-MI), and Collin Peterson (D-MN). Additional support for this is critical!

Please take a moment to contact your House representative to request they sign on.

Look up your elected officials’ phone numbers.

Here is what you say:

Hi, my name is _________ and I am a constituent of Congressman/woman _________. I am calling to request for your boss to sign on to a Dear Colleague letter circulated by Congresswoman Maloney in support of $50 million in cancer research funding in the defense budget that has already been passed by the Senate committee.

Thank you!

Also...

In Other News

Share:

Facebook
Twitter
LinkedIn